drugset / Trial / NCT00384553
Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study investigates toxicity and efficacy of 2 x R-DHAP followed by High dose chemotherapy R-TEC and autologous stem cell transplantation in patients with relapsed or refractory aggressive Non- Hodgkins's Lymphoma.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Dexamethasone | Small molecule | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Rituximab | Monoclonal antibody | — | — |
| Subject | Treosulfan | Small molecule | — | — |